Stock Scorecard

Stock Summary for Outset Medical Inc (OM) - $3.70 as of 12/22/2025 5:41:02 PM EST

Total Score

10 out of 30

Safety Score

36 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for OM

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for OM

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for OM

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for OM

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for OM (36 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 10
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for OM

Bronstein, Gewirtz & Grossman, LLC Encourages Outset Medical, Inc. (OM) Investors to Inquire about Securities Investigation 12/21/2025 4:09:00 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM 12/21/2025 1:09:00 PM
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Outset Medical, Inc. (OM) And Encourages Investors to Reach Out 12/19/2025 4:09:00 PM
The Market Doesn't Like What It Sees From Outset Medical, Inc.'s (NASDAQ:OM) Revenues Yet As Shares Tumble 27% 12/19/2025 12:09:00 PM
The Market Doesn't Like What It Sees From Outset Medical, Inc.'s (NASDAQ:OM) Revenues Yet As Shares Tumble 27% 12/19/2025 11:28:00 AM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM 12/18/2025 12:10:00 PM
Bronstein, Gewirtz & Grossman, LLC Is Investigating Outset Medical, Inc. (OM) And Encourages Stockholders to Connect 12/18/2025 12:10:00 PM
RBC Adjusts Price Target on Outset Medical to $7 From $17, Maintains Sector Perform Rating 12/17/2025 4:09:00 PM
Bronstein, Gewirtz & Grossman, LLC Is Investigating Outset Medical, Inc. (OM) And Encourages Stockholders to Connect 12/17/2025 4:09:00 PM
Outset Medical price target lowered to $7 from $17 at RBC Capital 12/17/2025 2:09:00 PM

Financial Details for OM

Company Overview
Ticker OM
Company Name Outset Medical Inc
Country USA
Description Outset Medical, Inc. is a pioneering medical technology company headquartered in San Jose, California, focused on revolutionizing hemodialysis treatment through its innovative Tablo system. This user-centric technology enhances the efficiency and accessibility of dialysis, addressing significant pain points in renal care and improving patient outcomes. With a robust commitment to innovation and operational excellence, Outset is uniquely positioned for growth within the rapidly evolving healthcare landscape, presenting a compelling investment opportunity for institutional investors looking to engage with transformative advancements in medical technology and renal care solutions.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 9/30/2025
Next Earnings Date N/A

Stock Price History
Last Day Price 3.70
Price 4 Years Ago 691.35
Last Day Price Updated 12/22/2025 5:41:02 PM EST
Last Day Volume 271,718
Average Daily Volume 748,415
52-Week High 25.35
52-Week Low 3.59
Last Price to 52 Week Low 3.06%

Valuation Measures
Trailing PE N/A
Industry PE 41.90
Sector PE 53.39
5-Year Average PE -76.82
Free Cash Flow Ratio 1.84
Industry Free Cash Flow Ratio 28.74
Sector Free Cash Flow Ratio 33.77
Current Ratio Most Recent Quarter 7.09
Total Cash Per Share 2.01
Book Value Per Share Most Recent Quarter 7.78
Price to Book Ratio 0.49
Industry Price to Book Ratio 4.40
Sector Price to Book Ratio 49.15
Price to Sales Ratio Twelve Trailing Months 0.56
Industry Price to Sales Ratio Twelve Trailing Months 7.19
Sector Price to Sales Ratio Twelve Trailing Months 14.97
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 0

Share Statistics
Total Shares Outstanding 18,153,100
Market Capitalization 67,166,470
Institutional Ownership 98.97%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 25.94%
Reported EPS 12 Trailing Months -11.56
Reported EPS Past Year -4.77
Reported EPS Prior Year -12.44
Net Income Twelve Trailing Months -87,800,000
Net Income Past Year -127,976,000
Net Income Prior Year -172,797,000
Quarterly Revenue Growth YOY 2.70%
5-Year Revenue Growth 49.79%
Operating Margin Twelve Trailing Months -53.70%

Balance Sheet
Total Cash Most Recent Quarter 36,437,000
Total Cash Past Year 124,014,000
Total Cash Prior Year 68,509,000
Net Cash Position Most Recent Quarter -59,087,000
Net Cash Position Past Year -73,361,000
Long Term Debt Past Year 197,375,000
Long Term Debt Prior Year 130,113,000
Total Debt Most Recent Quarter 95,524,000
Equity to Debt Ratio Past Year 0.12
Equity to Debt Ratio Most Recent Quarter 0.60
Total Stockholder Equity Past Year 26,819,000
Total Stockholder Equity Prior Year 122,886,000
Total Stockholder Equity Most Recent Quarter 142,365,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months -53,912,000
Free Cash Flow Per Share Twelve Trailing Months -2.97
Free Cash Flow Past Year -117,215,000
Free Cash Flow Prior Year -134,813,000

Options
Put/Call Ratio 11.50
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -1.23
MACD Signal -1.51
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 2.02
RSI 24.27
50-Day SMA 13.52
150-Day SMA 90.51
200-Day SMA 160.78

System
Modified 12/20/2025 6:14:46 AM EST